To not answer even the "easy" questions was very weird. Can/will you submit to another HREC should be a question that any CEO of a biotech could answer: Section 5.3 of the National Statement on Ethical Conduct in Human Research states that "[an] institution has a responsibility to eliminate any unnecessary duplication of review". As well as it clearly failing the "pub test" to shop around for another HREC if you have had a rejection already.
- Forums
- ASX - By Stock
- NSB
- Ann: Investor Update Webinar
Ann: Investor Update Webinar, page-31
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.218M |
Open | High | Low | Value | Volume |
4.1¢ | 4.3¢ | 4.0¢ | $1.369K | 33.15K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 90000 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 6579 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 90000 | 0.039 |
1 | 100000 | 0.038 |
2 | 296850 | 0.037 |
2 | 225000 | 0.036 |
1 | 200000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 6579 | 1 |
0.043 | 53158 | 3 |
0.045 | 20000 | 1 |
0.050 | 85611 | 4 |
0.051 | 83976 | 2 |
Last trade - 10.11am 02/09/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |